Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies

被引:30
|
作者
Ochoa, Sebastian [1 ]
Ding, Li [1 ]
Kreuzburg, Samantha [1 ]
Treat, Jennifer [2 ]
Holland, Steven M. [1 ]
Zerbe, Christa S. [1 ]
机构
[1] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, Bethesda, MD 20892 USA
[2] Med Sci & Comp, Rockville, MD USA
基金
美国国家卫生研究院;
关键词
daratumumab; mycobacteria; disseminated; interferon gamma; autoantibodies;
D O I
10.1093/cid/ciaa1086
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Patients with autoantibodies to interferon-gamma (IFN-gamma) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-gamma who had progressive infection, resulting in clinical and radiographic improvement.
引用
收藏
页码:2206 / 2208
页数:3
相关论文
共 50 条
  • [11] Anti-interferon-γ antibodies in the treatment of autoimmune diseases
    Skurkovich, B
    Skurkovich, S
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (01) : 52 - 57
  • [12] Anti-Interferon Gamma Autoantibody and Disseminated Nontuberculous Mycobacteria Infection: What Should Be Done to Improve Its Clinical Outcome?
    Koizumi, Yusuke
    Mikamo, Hiroshige
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : 2209 - 2211
  • [13] Anti-CD38 antibody for refractory acquired hemophilia A
    Liu, Wei
    Liu, Jiaying
    Xue, Feng
    Yang, Renchi
    Zhang, Lei
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (06) : 1515 - 1518
  • [14] Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
    Lee, Hyun Tae
    Kim, Yujin
    Park, Ui Beom
    Jeong, Tae Jun
    Lee, Sang Hyung
    Heo, Yong-Seok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 536 : 26 - 31
  • [15] Expanding anti-CD38 immunotherapy for lymphoid malignancies
    Wang, Xu
    Yu, Xinfang
    Li, Wei
    Neeli, Praveen
    Liu, Ming
    Li, Ling
    Zhang, Mingzhi
    Fang, Xiaosheng
    Young, Ken H.
    Li, Yong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [16] Expanding anti-CD38 immunotherapy for lymphoid malignancies
    Xu Wang
    Xinfang Yu
    Wei Li
    Praveen Neeli
    Ming Liu
    Ling Li
    Mingzhi Zhang
    Xiaosheng Fang
    Ken H. Young
    Yong Li
    Journal of Experimental & Clinical Cancer Research, 41
  • [17] Talaromyces marneffei infection with IFNGR1 gene mutation in a patient with negative Anti-Interferon-γ autoantibodies
    Li, Shiyang
    Cao, Xianwei
    Guo, Zhuxiu
    Wang, Jian
    Tong, Jianbo
    Zhang, Zhibin
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2024, 99 (02) : 233 - 237
  • [18] Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma
    Quach, Hang
    Benson, Simon
    Haysom, Helen
    Wilkes, Anne-Marie
    Zacher, Nicole
    Cole-Sinclair, Merrole
    Prince, Henry Miles
    Mollee, Peter
    Spencer, Andrew
    Ho, Phoebe Joy
    Harrison, Simon J.
    Lee, Cindy
    Augustson, Bradley
    Daly, James
    INTERNAL MEDICINE JOURNAL, 2018, 48 (02) : 210 - 220
  • [19] Treatment Dilemmas in Disseminated Nontuberculous Mycobacterial Infections With Interferon-gamma Autoantibodies
    King, Elizabeth M.
    Weaver, Victoria K.
    Kestler, Mary H.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
  • [20] Refractory Mycobacterium avium Complex Pneumonia and Anti-Interferon-γ Autoantibodies A Case Report
    Saba, Marian
    Greene, John N.
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2019, 27 (02) : 110 - 113